IRIS Accounts Production v23.2.0.158 11787312 Board of Directors 1.2.22 31.1.23 31.1.23 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary D 1.00000 3185 5 2857 13430 11090 10240 5048 3185 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure117873122022-01-31117873122023-01-31117873122022-02-012023-01-31117873122021-01-31117873122021-02-012022-01-31117873122022-01-3111787312ns16:EnglandWales2022-02-012023-01-3111787312ns15:PoundSterling2022-02-012023-01-3111787312ns11:Director12022-02-012023-01-3111787312ns11:PrivateLimitedCompanyLtd2022-02-012023-01-3111787312ns11:SmallEntities2022-02-012023-01-3111787312ns11:AuditExempt-NoAccountantsReport2022-02-012023-01-3111787312ns11:SmallCompaniesRegimeForDirectorsReport2022-02-012023-01-3111787312ns11:SmallCompaniesRegimeForAccounts2022-02-012023-01-3111787312ns11:FullAccounts2022-02-012023-01-3111787312ns11:OrdinaryShareClass12022-02-012023-01-3111787312ns11:OrdinaryShareClass22022-02-012023-01-3111787312ns11:OrdinaryShareClass32022-02-012023-01-311178731242ns11:Director22022-01-311178731242ns11:Director22021-01-311178731242ns11:Director22022-02-012023-01-311178731242ns11:Director22021-02-012022-01-311178731242ns11:Director22023-01-311178731242ns11:Director22022-01-3111787312ns6:CurrentFinancialInstruments2023-01-3111787312ns6:CurrentFinancialInstruments2022-01-3111787312ns6:ShareCapital2023-01-3111787312ns6:ShareCapital2022-01-3111787312ns6:RetainedEarningsAccumulatedLosses2023-01-3111787312ns6:RetainedEarningsAccumulatedLosses2022-01-3111787312ns11:RegisteredOffice2022-02-012023-01-3111787312ns6:FurnitureFittings2022-01-3111787312ns6:FurnitureFittings2022-02-012023-01-3111787312ns6:FurnitureFittings2023-01-3111787312ns6:FurnitureFittings2022-01-3111787312ns6:WithinOneYearns6:CurrentFinancialInstruments2023-01-3111787312ns6:WithinOneYearns6:CurrentFinancialInstruments2022-01-3111787312ns11:OrdinaryShareClass12023-01-3111787312ns11:OrdinaryShareClass22023-01-3111787312ns11:OrdinaryShareClass32023-01-3111787312ns11:Director22022-02-012023-01-3111787312ns11:Director112022-01-3111787312ns11:Director112021-01-3111787312ns11:Director112022-02-012023-01-3111787312ns11:Director112021-02-012022-01-3111787312ns11:Director112023-01-3111787312ns11:Director112022-01-31
REGISTERED NUMBER: 11787312 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st January 2023

for

Crosbie Medical Limited

Crosbie Medical Limited (Registered number: 11787312)






Contents of the Financial Statements
for the Year Ended 31st January 2023




Page

Balance Sheet 1

Notes to the Financial Statements 2


Crosbie Medical Limited (Registered number: 11787312)

Balance Sheet
31st January 2023

31.1.23 31.1.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 4,189 1,424

CURRENT ASSETS
Debtors 5 229 3,185
Cash at bank 73,791 54,067
74,020 57,252
CREDITORS
Amounts falling due within one year 6 10,733 6,458
NET CURRENT ASSETS 63,287 50,794
TOTAL ASSETS LESS CURRENT
LIABILITIES

67,476

52,218

PROVISIONS FOR LIABILITIES 1,000 271
NET ASSETS 66,476 51,947

CAPITAL AND RESERVES
Called up share capital 7 203 203
Retained earnings 66,273 51,744
SHAREHOLDERS' FUNDS 66,476 51,947

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st January 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st January 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9th October 2023 and were signed on its behalf by:





Dr P Crosbie - Director


Crosbie Medical Limited (Registered number: 11787312)

Notes to the Financial Statements
for the Year Ended 31st January 2023

1. COMPANY INFORMATION

Crosbie Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11787312

Registered office: First Floor
49 Peter Street
Manchester
M2 3NG

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

Crosbie Medical Limited (Registered number: 11787312)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2023

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1st February 2022 1,899
Additions 3,581
At 31st January 2023 5,480
DEPRECIATION
At 1st February 2022 475
Charge for year 816
At 31st January 2023 1,291
NET BOOK VALUE
At 31st January 2023 4,189
At 31st January 2022 1,424

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.23 31.1.22
£    £   
Trade debtors 229 -
Directors' current accounts - 3,185
229 3,185

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.23 31.1.22
£    £   
Tax 4,971 5,731
Directors' current accounts 5,048 -
Accrued expenses 714 727
10,733 6,458

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.23 31.1.22
value: £    £   
100 Ordinary A £1 100 100
100 Ordinary B £1 100 100
3 Ordinary D £1 3 3
203 203

Crosbie Medical Limited (Registered number: 11787312)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2023

7. CALLED UP SHARE CAPITAL - continued

On 5th April 2023 1 Ordinary C shares each of £1 were allotted, called up and fully paid at par.

The A and B Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The C and D Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A, B, C and D Shares rank pari passu in respect of dividend and capital distribution rights.

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st January 2023 and 31st January 2022:

31.1.23 31.1.22
£    £   
Dr P Crosbie and Dr E Crosbie
Balance outstanding at start of year 3,185 (5 )
Amounts advanced 2,857 13,430
Amounts repaid (11,090 ) (10,240 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (5,048 ) 3,185

The loan is repayable on demand and no interest was charged during the period.

9. ULTIMATE CONTROLLING PARTY

The controlling party is Dr P Crosbie.